Park Dental Partners (NASDAQ:PARK) Rating Increased to Buy at Wall Street Zen

Key Points

• Wall Street Zen upgraded Park Dental Partners to “Buy” from “Hold.” Analysts’ overall consensus is “Moderate Buy,” with a $28.50 target price, compared with recent targets of $27.00 from Northland Securities and $30.00 from Craig Hallum.
• PARK shares opened at $22.97, while the company reported quarterly EPS of $0.30 on revenue of $61.21 million. Analysts expect full-year EPS of $0.36.
• Several institutional investors recently initiated positions in Park Dental Partners, including Kennedy Capital Management, Heartland Advisors, Pacific Ridge Capital Partners, Russell Investments Group and Boston Partners.

Park Dental Partners (NASDAQ:PARK - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "hold" rating to a "buy" rating in a note issued to investors on Saturday.

Several other equities research analysts have also recently weighed in on PARK. Zacks Research cut shares of Park Dental Partners from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, June 3rd. Weiss Ratings raised shares of Park Dental Partners from a "sell (e)" rating to a "sell (e+)" rating in a report on Tuesday, June 9th. Northland Securities set a $27.00 price objective on shares of Park Dental Partners in a research report on Thursday. Finally, Craig Hallum reaffirmed a "buy" rating and set a $30.00 price objective on shares of Park Dental Partners in a research note on Friday. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Park Dental Partners has an average rating of "Moderate Buy" and a consensus target price of $28.50.

Park Dental Partners Stock Performance

Shares of PARK stock opened at $22.97 on Friday. The company has a market capitalization of $103.82 million and a P/E ratio of 31.04. Park Dental Partners has a fifty-two week low of $9.53 and a fifty-two week high of $26.79. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.07 and a current ratio of 1.07. The stock has a 50 day moving average price of $19.52 and a two-hundred day moving average price of $18.52.

Park Dental Partners (NASDAQ:PARK - Get Free Report) last issued its earnings results on Wednesday, March 25th. The company reported $0.30 earnings per share (EPS) for the quarter. The firm had revenue of $61.21 million during the quarter. Analysts expect that Park Dental Partners will post 0.36 earnings per share for the current year.

Hedge Funds Weigh In On Park Dental Partners

Hedge funds and other institutional investors have recently made changes to their positions in the business. Kennedy Capital Management LLC bought a new stake in Park Dental Partners in the fourth quarter valued at $3,478,000. Heartland Advisors Inc. bought a new position in Park Dental Partners in the 2nd quarter worth $4,310,000. Pacific Ridge Capital Partners LLC bought a new position in Park Dental Partners in the 4th quarter worth $2,316,000. Russell Investments Group Ltd. purchased a new stake in shares of Park Dental Partners in the 4th quarter worth about $1,522,000. Finally, Boston Partners purchased a new stake in shares of Park Dental Partners in the 4th quarter worth about $576,000.

Park Dental Partners Company Profile

Park Dental Partners NASDAQ: PARK is a dental support organization that provides business and administrative services to affiliated dental practices. The company focuses on enabling dental clinicians to concentrate on patient care by delivering centralized non-clinical functions that support day-to-day operations and practice growth.

Services typically offered by Park Dental Partners include practice management, billing and revenue cycle management, procurement and supply-chain support, information technology, human resources, marketing and patient acquisition, and regulatory and compliance assistance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source